このエントリーをはてなブックマークに追加
ID 63759
FullText URL
Author
Nomura, Emi Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Omote, Yoshio Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Takemoto, Mami Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University ORCID Kaken ID
Hishikawa, Nozomi Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Kaken ID
Nakano, Yumiko Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University ORCID
Yunoki, Taijun Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Morihara, Ryuta Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University ORCID Kaken ID researchmap
Sasaki, Tatsuya Department of Neurological Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Akagawa, Hiroyuki Tokyo Women's Medical University Institute for Integrated Medical Sciences
Abe, Koji Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Kaken ID publons researchmap
Yamashita, Toru Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama University ORCID Kaken ID researchmap
Abstract
Cerebral cavernous malformations (CCMs) are congenital abnormalities of cerebral vessels. Surgical resection is rarely considered for the control of epilepsy in a first seizure patient with vascular malformation. In contrast, lesions that produce repetitive or progressive symptoms should be considered for surgical resection as treatment. Herein, we report a Japanese patient with a CCM2 mutation, c.609G>A (p.K203K) substitution, who showed drug-resistant epilepsy and dramatic improvement after surgical resection.
Keywords
CCM2
cerebral cavernous malformation
drug-resistant epilepsy
Note
This is the peer reviewed version of the following article: [Nomura, E, Omote, Y, Takemoto, M, et al. A Japanese case of successful surgical resection of cerebral cavernous malformations with a CCM2 mutation. Neurol Clin Neurosci. 2022; 10: 255- 258. doi: 10.1111/ncn3.12649], which has been published in final form at [https://doi.org/10.1111/ncn3.12649]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages there of by third parties from platforms, services and websites other than Wiley Online Library must be prohibited.
Published Date
2022-06-15
Publication Title
Neurology and Clinical Neuroscience
Volume
volume10
Issue
issue5
Publisher
Wiley
Start Page
255
End Page
258
ISSN
2049-4173
Content Type
Journal Article
language
English
OAI-PMH Set
岡山大学
Copyright Holders
© 2022 Japanese Society of Neurology and John Wiley & Sons Australia, Ltd.
File Version
author
DOI
Web of Science KeyUT
Related Url
isVersionOf https://doi.org/10.1111/ncn3.12649
Citation
Nomura, E, Omote, Y, Takemoto, M, et al. A Japanese case of successful surgical resection of cerebral cavernous malformations with a CCM2 mutation. Neurol Clin Neurosci. 2022; 10: 255- 258. doi: 10.1111/ncn3.12649
Funder Name
Japan Agency for Medical Research and Development